New Zealand joins a growing list of countries exploring psychedelic-assisted therapy. In 2023, Australia became the first ...

In a phase 2 trial, about half of cancer patients reported sustained reductions in depression and anxiety 2 years after a ...

Draig Therapeutics has been awarded £107m to advance the development of novel therapies for major neuropsychiatric disorders ...

Fremanezumab vs placebo significantly reduced monthly migraine days and depressive symptoms in patients with migraine and comorbid major depressive disorder.

More than 40% of patients with systemic lupus erythematosus in a large international study reported insufficient levels of physical activity, with low activity levels correlated to worsening of ...

On today’s edition of “CT BUZZ,” Reporter Jillian Andrews sat down with Jayesh Kamath, MD, PhD, Director of the Psychiatry ...

A pilot study involving psilocybin-assisted therapy found possible antidepressant effects for people with bipolar II disorder ...

The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...

About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy.

Magic mushrooms might be key to quelling depression among people battling cancer. A single dose of psilocybin provided ...

People with severe depression who receive electroshock therapy are significantly less likely to commit suicide, a new ...

Health 419 is the area’s first to administer treatments with Exomind, an updated transcranial magnetic stimulator ...